http://biotechbistro.com/forum/tags/capital-crunch The Business of Biotechnology en-US Sat, 04 Sep 2010 20:23:43 +0000 bbpress 1.0-alpha-4 q http://biotechbistro.com/forum/search.php http://biotechbistro.com/forum/topic/biopharma-sentiment-takes-a-plunge#post-12 Wed, 04 Mar 2009 06:52:14 +0000 laravmarks 12@http://biotechbistro.com/forum/ <p>Silico Research has released the findings of its annual survey of sentiment in the biopharma industry. As might be expected sentiment has taken a major turn for the worse with a net 38% of respondents seeing the prospects for the industry as declining over the next year. In 2008 a net 30% saw the prospects for the industry improving over the next year.</p> <p>This year a net 62% of respondents reported that the prospects for the industry are currently worse than this time last year. The state of capital markets was the most often cited reason for the decline in sentiment in the industry. The decline in sentiment was particularly pronounced in English speaking countries and the biotechnology sector. The survey was conducted during February 2009 and 103 senior executives in the industry took part in the survey.</p> <p>However, the capital crunch means that alliances with larger companies are more vital than ever with a net 64% of respondents viewing alliances as more important to their organisation in 2009 compared to 2008.</p> <p>For more information about the survey please email <a href="mailto:Lara@silico-research.com">Lara@silico-research.com</a></p> <p>Silico Research is a research consultancy that is a trusted advisor to leading organisations on partnering, alliances, relationships and reputation management both within the organisation and externally. What sets Silico Research apart is the evidence-based nature of its analysis. Quantitative and qualitative research of the highest quality using customised survey and focus groups are the core of Silico Research’s products and services. Silico's clients come from a wide range of public and private sectors, including the life sciences, healthcare, technology, energy and telecommunication. </p>